Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1391-1400 Newer>

Managed Care August 2004	MCOs, Drug Manufacturers Have Lots of PR Work to Do Managed care companies, and pharmaceuticals especially, receive disheartening numbers in a consumer satisfaction poll.
Managed Care August 2004 John Carroll	'Healthy Mae' Just Might Be Frist's Biggest Legacy The senate majority leader, a surgeon who owns a large stake in a chain of hospitals, puts forth far-reaching proposals for reforming the health care system.
Managed Care August 2004	Medicaid Fees Rise, But Still Below Medicare A recent study reports that 30 states raised their Medicaid fees at or above the rate of inflation, including 10 that raised physician fees by more than 35%.
Managed Care August 2004 Thomas Morrow	10,000 Cells on a Chip Signal Start of New Era of Diagnosis Diseases will soon be defined by biochemical pathways and genetic interactions. Biochips may identify patients likely to respond to therapeutic agents. All of this is a big deal for health plans.
Managed Care August 2004	Medical Debt Found to Hinder Access With the emergence of consumer-directed health plans, both privately and publicly insured people may face growing out-of-pocket costs. Medical bill problems may limit the appeal of the new health savings accounts passed as part of the 2003 Medicare reform.
The Motley Fool August 31, 2004 Charly Travers	Hidden Value With QLT The market might overlook the drug maker's promising programs. Over the next six months, biotech investors should keep an eye on this one.
Fast Company September 2004 Linda Tischler	The Trials of ImClone A founder in handcuffs, financials in disarray, and a vital product in doubt-for CEO Daniel Lynch, it was the turnaround from hell.
Fast Company September 2004 Chuck Salter	Mr. Inside Speaks Out Former Medtronic CEO Bill George has split with his brethren to make an impassioned case for courageous leadership.
The Motley Fool August 30, 2004 W.D. Crotty	Warning Bells for Specialty Pharmacy? Accredo Health lowers earnings guidance for 2005.
The Motley Fool August 27, 2004 W.D. Crotty	deCODE This deCODE genetics' auditor's resignation provides a buying opportunity for those who buy story stocks.
<Older 1391-1400 Newer> Return to current articles.